Cancer treatment and immune system regulation through FAT10 pathway inhibition
Described herein are methods of inhibiting mitosis, treating cancer and/or treating immune disorders through the use of agents that inhibit FAT 10 and/or the FAT 10 pathway.
1. A method of treating type I diabetes in a subject comprising administering to the subject an inhibitory nucleic acid specific for an mRNA that encodes FAT10.
2. The method of claim 1 , wherein the inhibitory nucleic acid is of an siRNA.
3. The method of claim 1 , wherein the inhibitory nucleic acid is an shRNA.
4. The method of claim 1 , wherein the inhibitory nucleic acid is an antisense RNA molecule.
5. The method of claim 1 , wherein the inhibitory nucleic acid is a nucleic acid that encodes an siRNA.
6. The method of claim 1 , wherein the inhibitory nucleic acid is a nucleic acid that encodes an shRNA.
7. The method of claim 1 , wherein the inhibitory nucleic acid is a nucleic acid that encodes and antisense RNA molecule.